Media Coverage

MPO: Early Detection of Acute Myocardial Infarction Using Microfluidics

March 28, 2023

MPO article on the use of microfluidics for early myocardial infarction detection.

The March 28, 2023 edition of Medical Product Outsourcing (MPO) features Early Detection of Acute Myocardial Infarction Using Microfluidics. Is it possible to use the technology to detect a heart attack or a stroke early on? by Lorenzo Gutierrez, Microfluidics Manager at StarFish Medical. The online exclusive explores the potential of wearable microfluidic devices to detect a heart attach or a stroke early on.

“While a heart attack or an acute myocardial infarction is often fatal, there is no commercial device available that can detect a heart attack before it happens. Instead, we’re left to diagnose the disease in retrospect.” Gutierrez discusses the capabilities of microfluidics as a potential tool for early MI detection and concludes: “Microfluidic devices with a biosensor can potentially detect specific biomarkers to determine an impending heart attack event when only one or two symptoms appear.”

However, Gutierrez remains cautious despite the potential of microfluidics in diagnostic tools as “there is still a lot of work ahead to determine the most accurate biomarker as well as the biosensor that will determine with certainty that the collected data is accurate to detect a possible heart attack.”

Lorenzo Gutierrez is the StarFish Medical Microfluidics Manager. Lorenzo has extensive experience translating point of care assays to microfluidic cartridges. His microfluidics portfolio includes developing a polyvalence instrument for early infant diagnostics at Chipcare.

« All Media Coverage

Join over 6000 medical device professionals who receive our engineering, regulatory and commercialization insights and tips every month.